Literature DB >> 18426264

Risk factors for in-stent restenosis after vertebral ostium stenting.

Robert A Taylor1, Farhan Siddiq, M Fareed K Suri, Coleman O Martin, Minako Hayakawa, John C Chaloupka.   

Abstract

PURPOSE: To determine whether vascular risk factors, underlying vessel diameter, and/or the type of stent affect restenosis rates for vertebral ostium stents.
METHODS: A single-center retrospective analysis was conducted of 44 patients (31 men; mean age 61 years, range 32-81) who underwent stenting of 48 ostial lesions in the vertebral arteries between 1999 and 2005. Only patients who underwent angiographic follow-up were included in the analysis. Cox regression analysis was utilized for risk factor association with binary restenosis (> or =50% versus <50%). Stent types and stent categories were compared for differences in binary restenosis rates and lumen gain at follow-up angiography.
RESULTS: Twenty-three (48%) of 48 lesions had > or =50% stenosis at a mean follow-up of 7.7 months. Cigarette smoking was associated with higher binary restenosis rates (p=0.025), while hypertension, diabetes, hyperlipidemia, history of neck radiation, and known coronary artery and/or peripheral vascular disease were not. Reduced binary restenosis rates and improved lumen gain were seen in cobalt chromium balloon-expandable stents compared to non-cobalt chromium stents (p=0.002 and p=0.002, respectively), stainless steel balloon-expandable stents (p=0.005 and p=0.005), and the S670 stent (p=0.069 and p=0.069). The size of stent used was not associated with risk of restenosis (p=0.756).
CONCLUSIONS: Cobalt chromium stents were associated with reduced restenosis, while smoking was associated with increased restenosis risk.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18426264     DOI: 10.1583/07-2175.1

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  6 in total

1.  Endovascular treatment of extracranial vertebral artery stenosis.

Authors:  Burak Kocak; Bora Korkmazer; Civan Islak; Naci Kocer; Osman Kizilkilic
Journal:  World J Radiol       Date:  2012-09-28

2.  Use of self-expanding stents for the treatment of vertebral artery ostial stenosis: a single center experience.

Authors:  Sun Young Chung; Deok Hee Lee; Jin Woo Choi; Byung Se Choi; Hyun Sin In; Sun Mi Kim; Choong Gon Choi; Sang Joon Kim; Dae Chul Suh
Journal:  Korean J Radiol       Date:  2010-02-22       Impact factor: 3.500

3.  Vertebral artery ostial stent placement for atherosclerotic stenosis in 72 consecutive patients: clinical outcomes and follow-up results.

Authors:  Robert A Taylor; Farhan Siddiq; Muhammad Zeeshan Memon; Adnan I Qureshi; Gabriela Vazquez; Minako Hayakawa; John C Chaloupka
Journal:  Neuroradiology       Date:  2009-05-13       Impact factor: 2.804

4.  Seven years' follow-up of comparative study between stenting and medication for treatment of symptomatic vertebrobasilar artery stenosis.

Authors:  Jun Wang; Changyang Zhong; Yan Zhang; Yingnan Wei; Huili Liu; Chunli Wu; Yongxing Yan
Journal:  Interv Neuroradiol       Date:  2017-10-23       Impact factor: 1.610

5.  Treatment of stenoses of vertebral artery origin using short drug-eluting coronary stents: improved follow-up results.

Authors:  Z Vajda; E Miloslavski; T Güthe; S Fischer; G Albes; A Heuschmid; H Henkes
Journal:  AJNR Am J Neuroradiol       Date:  2009-09-03       Impact factor: 3.825

6.  Comparison of drug-eluting and bare metal stents for extracranial vertebral artery stenting.

Authors:  Damian R Maciejewski; Piotr Pieniazek; Lukasz Tekieli; Piotr Paluszek; Tadeusz Przewlocki; Tomasz Tomaszewski; Roman Machnik; Mariusz Trystula; Jacek Legutko; Anna Kablak-Ziembicka
Journal:  Postepy Kardiol Interwencyjnej       Date:  2019-09-18       Impact factor: 1.426

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.